QUANTRO Therapeutics Secures 12-Month AI Drug Discovery Grant

QUANTRO Therapeutics secured a 12-month, non-dilutive Austrian research grant to expand ASCEND, its AI-powered drug-discovery platform. The award size was not disclosed.